SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Feb. 03, 2018	Jan. 28, 2017
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	3,010,720	4,079,050
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	0
Number of Underlying Shares, Forfeited or expired (in shares)	(1,068,330)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 49.35	$ 47.49
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0.00
Weighted-Average Exercise Price, Exercised (in dollars per share)	0.00
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 42.59
Aggregate Intrinsic Value, Outstanding	$ 29,097
Weighted-Average Remaining Contractual Life, Outstanding	1 year 10 months 24 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	2,783,169
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 51.31
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 15,771
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	1 year 6 months
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	214,132
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 25.68
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 8,870
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	7 years